Date | Insider | Price | Amount |
---|---|---|---|
4-19-2024 Insider Buy |
Scott Juda Director |
$8.32 CAGR » |
$246,296.96 29,603 shares |
4-19-2024 Insider Buy |
Mark William Lowdell Chief Scientific Officer |
$8.32 CAGR » |
$119,999.36 14,423 shares |
4-19-2024 Insider Buy |
Raymond Joseph Tesi President and CEO |
$8.32 CAGR » |
$149,992.96 18,028 shares |
4-19-2024 Insider Buy |
David J. Moss CFO, Treasurer & Secretary |
$8.32 CAGR » |
$149,992.96 18,028 shares |
5-27-2022 Insider Buy |
David J. Moss CFO, Treasurer & Secretary |
$6.42 CAGR » |
$68,649.00 10,700 shares |
11-17-2021 Insider Buy |
Scott Juda Director |
$13.55 CAGR » |
$33,875.00 2,500 shares |
8-21-2019 Insider Buy |
Scott Juda Director |
$6.00 CAGR » |
$30,000.00 5,000 shares |
8-20-2019 Insider Buy |
Raymond Joseph Tesi President & CEO |
$5.99 CAGR » |
$11,987.19 2,000 shares |
8-20-2019 Insider Buy |
David J. Moss CFO, Treasurer & Secretary |
$5.65 CAGR » |
$16,950.00 3,000 shares |
8-9-2019 Insider Buy |
Raymond Joseph Tesi President & CEO |
$7.03 CAGR » |
$14,058.29 2,000 shares |
6-3-2019 Insider Buy |
Scott Juda |
$6.00 CAGR » |
$60,000.00 10,000 shares |
5-6-2019 Insider Buy |
David J. Moss CFO, Treasurer & Secretary |
$10.71 CAGR » |
$53,550.00 5,000 shares |
5-2-2019 Insider Buy |
Raymond Joseph Tesi President & CEO |
$10.75 CAGR » |
$119,325.00 11,100 shares |
5-8-2019 Insider Buy |
Linda F. Powers |
$9.00 CAGR » |
$555,003.00 61,667 shares |
Also See: Institutional Holders of INMB
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/22/2024 | |
End date: | 04/23/2024 | |
Start price/share: | $10.62 | |
End price/share: | $10.14 | |
Dividends collected/share: | $0.00 | |
Total return: | -4.56% | |
Annualized Gain: | -1,666.12% | |
Starting investment: | $10,000.00 | |
Ending investment: | $9,544.00 | |
Years: | 0.00 |
INmune Bio Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent INmune Bio insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding INMB
Free INMB Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the INmune Bio Insider Buying occurred are:
MainStay CBRE Global Infrastructure Megatrends Term Fund Insider Buying |